5-Bromobenzo[c][1,2,5]oxadiazole

Modify Date: 2024-01-06 10:53:08

5-Bromobenzo[c][1,2,5]oxadiazole Structure
5-Bromobenzo[c][1,2,5]oxadiazole structure
Common Name 5-Bromobenzo[c][1,2,5]oxadiazole
CAS Number 51376-06-8 Molecular Weight 199.005
Density 1.8±0.1 g/cm3 Boiling Point 255.8±32.0 °C at 760 mmHg
Molecular Formula C6H3BrN2O Melting Point 73ºC
MSDS USA Flash Point 108.5±25.1 °C

 Names

Name 5-Bromobenzofurazan
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.8±0.1 g/cm3
Boiling Point 255.8±32.0 °C at 760 mmHg
Melting Point 73ºC
Molecular Formula C6H3BrN2O
Molecular Weight 199.005
Flash Point 108.5±25.1 °C
Exact Mass 197.942871
PSA 38.92000
LogP 2.46
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.661
Storage condition 2-8°C

 MSDS

Name: 5-Bromo-2 1 3-benzoxadiazole 97% Material Safety Data Sheet
Synonym: 5-Bromobenzofuraza
CAS: 51376-06-8
Section 1 - Chemical Product MSDS Name:5-Bromo-2 1 3-benzoxadiazole 97% Material Safety Data Sheet
Synonym:5-Bromobenzofuraza

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
51376-06-8 5-Bromo-2,1,3-benzoxadiazole 97% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 51376-06-8: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Needles
Color: brown
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 73 - 74 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C6H3BrN2O
Molecular Weight: 199.01

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen bromide, bromine.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 51376-06-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-Bromo-2,1,3-benzoxadiazole - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 51376-06-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 51376-06-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 51376-06-8 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Hazard Codes Xi:Irritant;
Risk Phrases R36/37/38
Safety Phrases S26-S37/39
HS Code 2934999090

 Synthetic Route

~69%

5-Bromobenzo[c][1,2,5]oxadiazole Structure

5-Bromobenzo[c]...

CAS#:51376-06-8

Literature: ENVIVO PHARMACEUTICALS, INC. Patent: WO2009/158393 A1, 2009 ; Location in patent: Page/Page column 100 ;

~54%

5-Bromobenzo[c][1,2,5]oxadiazole Structure

5-Bromobenzo[c]...

CAS#:51376-06-8

Literature: Manley, Paul W.; Acemoglu, Murat; Marterer, Wolfgang; Pachinger, Werner Organic Process Research and Development, 2003 , vol. 7, # 3 p. 436 - 445

~%

5-Bromobenzo[c][1,2,5]oxadiazole Structure

5-Bromobenzo[c]...

CAS#:51376-06-8

Literature: Manley, Paul W.; Acemoglu, Murat; Marterer, Wolfgang; Pachinger, Werner Organic Process Research and Development, 2003 , vol. 7, # 3 p. 436 - 445

~%

5-Bromobenzo[c][1,2,5]oxadiazole Structure

5-Bromobenzo[c]...

CAS#:51376-06-8

Literature: Manley, Paul W.; Acemoglu, Murat; Marterer, Wolfgang; Pachinger, Werner Organic Process Research and Development, 2003 , vol. 7, # 3 p. 436 - 445

~%

5-Bromobenzo[c][1,2,5]oxadiazole Structure

5-Bromobenzo[c]...

CAS#:51376-06-8

Literature: Vasil'ev; Struchkova; Sheremetev; Levinson; Varganov; Lyssenko Russian Chemical Bulletin, 2011 , vol. 60, # 11 p. 2306 - 2314 Izv. Akad. Nauk, Ser. Khim., 2011 , # 11 p. 2262 - 2269,8

~%

5-Bromobenzo[c][1,2,5]oxadiazole Structure

5-Bromobenzo[c]...

CAS#:51376-06-8

Literature: Lipilin, Dmitry L.; Smirnov, Oleg Yu.; Churakov, Aleksandr M.; Strelenko, Yuri A.; Ioffe, Sema L.; Tartakovsky, Vladimir A. European Journal of Organic Chemistry, 2002 , # 20 p. 3435 - 3446

~%

5-Bromobenzo[c][1,2,5]oxadiazole Structure

5-Bromobenzo[c]...

CAS#:51376-06-8

Literature: Tappi; Forni Annali di Chimica Applicata, 1949 , vol. 39, p. 338,342

 Customs

HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

2,1,3-Benzoxadiazole, 5-bromo-
5-Bromo-2,1,3-benzoxadiazole
5-Bromobenzo[c][1,2,5]oxadiazole